Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $16.5000 (1.44%) ($16.5000 - $16.5000) on Fri. Jul. 2, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.69% (three month average) | RSI | 53 | Latest Price | $16.5000(1.44%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -0.8% a day on average for past five trading days. | Weekly Trend | BCRX declines -0.7% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XBI(45%) IBB(40%) IWO(37%) ARKK(36%) ARKG(35%) | Factors Impacting BCRX price | BCRX will decline at least -2.345% in a week (0% probabilities). VIXM(-23%) UUP(-14%) VXX(-7%) TBT(-2%) IGOV(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.345% (StdDev 4.69%) | Hourly BBV | 1.8 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $15.94(3.51%) | 10 Day Moving Average | $16.4(0.61%) | 20 Day Moving Average | $16.47(0.18%) | To recent high | -4.2% | To recent low | 73.8% | Market Cap | $2.911b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |